• RSV NS3 Orchestrates Host Kinase Signaling to Balance Pathog

  2026-05-20

  Zhuang et al. (2025) uncover how Rice stripe virus (RSV) NS3 protein exploits host kinase signaling, specifically the OsSnRK3.25-OsCBL1/3-OsRBOHF pathway, to regulate both viral pathogenicity and transmission. This work advances understanding of plant-virus-vector co-survival and highlights precise molecular mechanisms underlying viral adaptation strategies.

• FH1 (Catalog No. B3700): Advancing iPS Hepatocyte Differenti

  2026-05-20

  This article addresses common laboratory challenges in generating mature hepatocyte-like cells and interprets how FH1 (Catalog No. B3700), supplied as SKU B3700, elevates reproducibility and data reliability. Through scenario-driven analysis, we demonstrate the compound's evidence-backed role in cultured hepatocyte function enhancement and offer actionable guidance for biomedical researchers.

• Letrozole as a Non-Steroidal Aromatase Inhibitor: Applied Wo

  2026-05-19

  Letrozole’s high specificity and reversible inhibition make it a versatile tool for dissecting estrogen biosynthesis and signaling in hormone-dependent cancer models. This article provides actionable, evidence-backed protocols and advanced troubleshooting strategies to enhance experimental reproducibility and interpretability in breast cancer research.

• BRCAness Profiling Predicts Olaparib Sensitivity in Mesothel

  2026-05-19

  Borchert et al. systematically profiled homologous recombination repair gene expression in malignant pleural mesothelioma (MPM) and demonstrated that BRCAness phenotypes, especially BAP1 mutations, sensitize cells to Olaparib (AZD2281). Their findings support targeted PARP inhibition as a promising strategy in a molecularly defined MPM subpopulation, with implications for patient stratification and combination therapy.

• EdU Flow Cytometry Assay Kits (Cy3): Deep Insights into Cell

  2026-05-18

  Explore how EdU Flow Cytometry Assay Kits (Cy3) empower advanced, artifact-free cell proliferation analysis and reveal new opportunities for pan-cancer biomarker validation. This cornerstone article offers a unique perspective on integrating cell cycle insights with oncogene research.

• SIS3 (Smad3 Inhibitor): Precision Tool for Fibrosis & TGF-β

  2026-05-18

  SIS3 stands out as a selective Smad3 inhibitor, enabling robust dissection of the TGF-β signaling pathway in fibrosis and renal disease models. Its workflow-friendly solubility and preclinical efficacy empower reproducible research, particularly in complex cellular and in vivo assays.

• Grazoprevir Hydrate: Translational Advances for Complex HCV

  2026-05-17

  Explore how Grazoprevir hydrate (MK-5172 hydrate) is reshaping hepatitis C virus replication inhibition in challenging patient cohorts. This in-depth review delivers new translational insights and practical assay guidance beyond conventional protocols.

• SFTSV NSs Disrupt DPP9 to Activate NLRP1/CARD8 Inflammasomes

  2026-05-16

  Liu et al. (2025) identify a novel mechanism by which the non-structural protein of SFTSV activates NLRP1 and CARD8 inflammasomes via targeted disruption of the DPP9-mediated ternary inhibitory complex. This work advances understanding of viral modulation of innate immunity and highlights critical regulatory checkpoints in inflammasome activation.

• S-Adenosylhomocysteine in Methylation Cycle Research Workflo

  2026-05-15

  S-Adenosylhomocysteine (SAH) from APExBIO enables precision control of methyltransferase activity and the SAM/SAH ratio in advanced metabolic and neural differentiation studies. This article details evidence-based protocols and troubleshooting strategies, making SAH indispensable for dissecting methylation-dependent pathways and metabolic dysfunction.

• Saquinavir: Optimized HIV Protease Inhibitor Workflows & Ins

  2026-05-15

  Saquinavir (APExBIO, A3790) empowers antiretroviral and translational research with validated, high-throughput workflows targeting HIV-1/2 protease. This article distills advanced permeability modeling, protocol enhancements, and troubleshooting strategies—bridging bench execution with scalable data-driven discovery.

• Neurotensin (CAS 39379-15-2): Mechanistic Insights and Spect

  2026-05-14

  Explore the advanced mechanistic role of Neurotensin as a Neurotensin receptor 1 activator, and discover how state-of-the-art spectral interference resolution is transforming GPCR trafficking mechanism studies. This cornerstone article offers unique assay decision guidance and practical protocol parameters for researchers in gastrointestinal and neurobiological fields.

• PTH (1-34) in Translational Research: Mechanisms, Models, an

  2026-05-14

  This article explores how Parathyroid hormone (1-34) (human) bridges mechanistic insight and translational strategy in bone metabolism and kidney disease research. It integrates evidence from recent studies to illuminate the peptide’s role in calcium regulation, disease modeling, and experimental reproducibility, offering practical guidance for translational researchers seeking to advance their projects beyond conventional product reviews.

• Canonical MCL-1 Function Drives Breast Cancer Cell Survival

  2026-05-13

  This article reviews evidence from Campbell et al. (2021), demonstrating that breast cancer cell dependence on MCL-1 is rooted in its canonical anti-apoptotic function. The findings clarify the mechanistic basis for targeting MCL-1 in breast cancer and inform future experimental designs for apoptosis-focused studies.

• Bedaquiline: Advanced Mechanistic Insights for TB and Cancer

  2026-05-13

  Explore how Bedaquiline, a diarylquinoline antibiotic, redefines multi-drug resistant tuberculosis and cancer stem cell research through mitochondrial targeting. This article offers new depth by connecting recent host-directed therapy breakthroughs to practical assay design.

• Tamsulosin in Translational Urology: Mechanisms to Clinical

  2026-05-12

  Explore how Tamsulosin—(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide—advances urological and smooth muscle research, bridging cellular mechanisms to patient outcomes. This thought-leadership article details mechanistic insights, experimental validation strategies, and translational guidance for researchers seeking reliable, reproducible results with APExBIO’s Tamsulosin, while integrating the latest prognostic biomarkers in prostate cancer.

16584 records 1/1106 page Next 12345 下5页 Last page